presence of inflammation 1 year [clinicaltrials_resource:7d46ae5ca95cd10e418f0e4f120ae744]
to determine the efficacy of metformin in avoiding deterioration of glucose intolerance to type 2 diabetes, as measured by inflammation through various recognized inflammation markers
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
presence of inflammation 1 year [clinicaltrials_resource:7d46ae5ca95cd10e418f0e4f120ae744]
to determine the efficacy of metformin in avoiding deterioration of glucose intolerance to type 2 diabetes, as measured by inflammation through various recognized inflammation markers
Bio2RDF identifier
7d46ae5ca95cd10e418f0e4f120ae744
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7d46ae5ca95cd10e418f0e4f120ae744
measure [clinicaltrials_vocabulary:measure]
presence of inflammation
time frame [clinicaltrials_vocabulary:time-frame]
description
to determine the efficacy of m ...... ecognized inflammation markers
identifier
clinicaltrials_resource:7d46ae5ca95cd10e418f0e4f120ae744
title
presence of inflammation 1 year
@en
type
label
presence of inflammation 1 yea ...... 6ae5ca95cd10e418f0e4f120ae744]
@en